2021. Bimekizumab Safety in Patients with Moderate to Severe Psoriasis: Analysis of Pooled Data from Phase 2 and 3 Clinical Trials. SKIN The Journal of Cutaneous Medicine. 5, 1 (Jan. 2021), s21. DOI:https://doi.org/10.25251/skin.5.supp.21.